Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease release » increased release (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease release » increased release (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
9
Lack of Brain Insulin Receptor Substrate-1 Causes Growth Retardation, with Decreased Expression of Growth Hormone-Releasing Hormone in the Hypothalamus
Published 2021“…Although the ability of the pituitary to secrete growth hormone (GH) remained intact, the amount of hypothalamic growth hormone-releasing hormone (GHRH) was significantly decreased and accordingly, the pituitary GH mRNA expression levels were impaired in these mice. …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation.
Published 2020“…(B) Oxygen consumption rates were measured using a Seahorse Bioscience XF96 extracellular flux analyzer in A375 melanoma cells treated with or without 1.0 μM 12-TPP (N = 4). At the 25 min mark, 1.0 μM 12-TPP was added to treatment A375 cells followed by the sequential addition of 2.5 μM oligomycin at the 60 min mark, 0.3 μM oligomycin at the 90 min mark, and 5.0 μM rotenone/antimycin A at the 120 min mark. …”
-
19
-
20